Skip to main content
. 2019 Nov 29;62(4):494–499. doi: 10.1111/dmcn.14415

Figure 1.

Figure 1

(a) Change in score between baseline and follow‐up for the intrathecal baclofen‐treated and control groups (treated with placebo). (b) Correlation between the Dyskinesia Impairment Scale (DIS) dystonia subscale and Barry–Albright Dystonia Scale (BADS) at baseline and (c) at follow‐up. [Color figure can be viewed at http://wileyonlinelibrary.com]